Holen Sie sich die Stockscreener-App
23.06
5.88%
1.28
Handel nachbörslich:
23.18
0.12
+0.52%
Schlusskurs vom Vortag:
$21.78
Offen:
$21.95
24-Stunden-Volumen:
1.45M
Relative Volume:
1.27
Marktkapitalisierung:
$1.98B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
36.60
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
-1.83%
1M Leistung:
-0.65%
6M Leistung:
+5.06%
1J Leistung:
+6.76%
1-Tages-Spanne:
$21.71
$23.20
1-Wochen-Bereich:
$21.26
$26.38
52-Wochen-Spanne:
$13.39
$26.76
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.06 | 1.87B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
271.81 | 236.90B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.90 | 83.09B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
287.10 | 74.87B | 260.93B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
294.43 | 65.86B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
281.99 | 33.07B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny’s Earnings Call Highlights Robust Growth and Strategic Partnerships - MSN
Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accelerate - MSN
PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance - TradingView
Progyny Exceeds Earnings Expectations, Analysts Expect Continued Growth in 2025 - AInvest
Progyny's Q2 2025 Earnings Call: Unpacking Contradictions in Sales Performance, Pricing Impact, and Margin Expectations - AInvest
Progyny, Inc. Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next - ca.finance.yahoo.com
Price momentum metrics for Progyny Inc. explainedFree Breakout Momentum Picks With Protection - Newser
What makes Progyny Inc. stock price move sharplyTechnical Long-Term Outlook and Recap Guide - Newser
Using R and stats models for Progyny Inc. forecastingChart Based Entry Tool for ROI Traders - Newser
Why Progyny Inc. stock attracts strong analyst attentionFuture Growth Stock Forecasting Strategy - Newser
Is Progyny Inc. a defensive stockFast Payout Trading Plans - newsyoung.net
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $28 to $30 - 富途牛牛
Progyny, Inc. (NASDAQ:PGNY) Q2 2025 Earnings Call Transcript - Insider Monkey
Advanced analytics toolkit walkthrough for Progyny Inc.Trading Volume Anomaly Summary and Insight - Newser
Progyny 2025 Q2 Earnings Net Income Grows 3.8% Despite Stock Sell-Off - AInvest
Can Progyny Inc. deliver consistent dividendsWealth Catalysts in Stocks - thegnnews.com
Progyny (NASDAQ:PGNY) Shares Gap Up After Analyst Upgrade - Defense World
PGNY News Today | Why did Progyny stock go down today? - MarketBeat
Progyny Outpaces Expectations And Lifts 2025 Outlook - Finimize
Cantor Fitzgerald reiterates Overweight rating on Progyny stock By Investing.com - Investing.com South Africa
Strong Financial Performance and Market Trends Support Buy Rating for Progyny - TipRanks
Progyny, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Progyny Q2 2025 beats EPS forecasts with strong growth - Investing.com
Progyny's Q2 Adjusted Earnings, Revenue Increase; 2025 Outlook Raised - MarketScreener
Zurcher Kantonalbank Zurich Cantonalbank Has $507,000 Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ... - Yahoo Finance
Progyny, Inc. Reports Record Q2 2025 Revenue - TipRanks
Transcript : Progyny, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Progyny's Q2 2024 Earnings: A Strategic Buy Opportunity Amid Strong EBITDA Growth and Aggressive Buybacks - AInvest
Progyny earnings beat by $0.32, revenue topped estimates - Investing.com Canada
Progyny: Q2 Earnings Snapshot - Erie News Now
Progyny reports Q2 adjusted EPS 48c, consensus 43c - TipRanks
Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic - TradingView
(PGNY) Progyny, Inc. Expects Q3 Revenue Range $290.0M$305.0M - MarketScreener
(PGNY) Progyny, Inc. Expects Q3 Adjusted EPS Range $0.37$0.40 - MarketScreener
Earnings Flash (PGNY) Progyny, Inc. Reports Q2 Revenue $332.9M, vs. FactSet Est of $320.1M - MarketScreener
Earnings Flash (PGNY) Progyny, Inc. Posts Q2 Adjusted EPS $0.48 per Share, vs. FactSet Est of $0.16 - MarketScreener
Progyny, Inc. Announces Second Quarter 2025 Results - Yahoo Finance
Progyny Earnings Report: Insights and ExpectationsNews and Statistics - IndexBox
Progyny Earnings: What To Look For From PGNY - Yahoo Finance
Three Low-Volatility Stocks to Reconsider: J.M. Smucker, Sherwin-Williams, and Progyny. - AInvest
Is Progyny Inc. a growth stock or a value stockGet daily updates on promising stocks - Jammu Links News
Is Progyny Inc. stock overvalued or undervaluedCapitalize on market momentum for big wins - Jammu Links News
What are the latest earnings results for Progyny Inc.Unlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Progyny Inc. stock higher in 2025High-octane gains - Jammu Links News
What is the dividend policy of Progyny Inc. stockRapid portfolio appreciation - Jammu Links News
Does Progyny Inc. stock perform well during market downturnsBreakout stock performance - Jammu Links News
What analysts say about Progyny Inc. stockPhenomenal wealth increase - Jammu Links News
How does Progyny Inc. generate profit in a changing economyRobust investment performance - Jammu Links News
What is Progyny Inc. company’s growth strategyAchieve unparalleled market performance - Jammu Links News
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):